Cancer and Women’s and Men’s Health
The American Cancer Society had estimated that by the end of 2012, more than 226,000 women would be diagnosed with new cases of breast cancer and more than 241,000 men would be diagnosed with new cases of prostate cancer (American Cancer Society, 2012a; American Cancer Society, 2012b). With such prevalence of women’s and men’s cancers, patient education and preventive services are essential. In clinical settings, advanced practice nurses must assist physicians in educating patients on risk factors, preventive services, and—especially for patients diagnosed with cancer—potential drug treatments. The clinical implications of women’s and men’s cancer greatly depend on early detection, which is primarily achieved through preventive services. In this Discussion, you consider the short-term and long-term implications of cancer and drug treatments associated with women’s and men’s health, as well as appropriate preventive services.
· Select a type of cancer associated with women’s or men’s health, such as breast, cervical, and ovarian cancer in women and prostate cancer in men.
· Search the Walden Library or other reputable sources for articles examining the type of cancer you selected.
· Consider the pathophysiology and drug treatments for patients diagnosed with the cancer you selected. If you are focusing on women’s health issues, consider how pregnancy and lactation might affect these treatment options.
· Reflect on short-term and long-term implications of this cancer and drug treatments for patients.
Questions to be addressed in my paper:
1. An explanation of the pathophysiology of the type of cancer you selected
2. describe the drug treatments used for patients with this type of cancer.
3. Explain short-term and long-term implications of the cancer and the drug treatments for patients.
4. Summary with Conclusion
1) 2-3 pages (addressing the 4 questions above excluding the title page and reference page).
2) Kindly follow APA format for the citation and references! References should be between the period of 2011 and 2016. Please utilize the references at least three below as much as possible and the rest from yours.
3) Make headings for each question.
· Huether, S. E., & McCance, K. L. (2012). Understanding pathophysiology (Laureate custom ed.). St. Louis, MO: Mosby.
o Chapter 31, “Structure and Function of the Reproductive Systems”
This chapter establishes a foundation for examining alterations of reproductive systems by examining the female and male reproductive systems. It covers the development of both reproductive systems and effects of aging on the systems.
o Chapter 32, “Alterations of the Reproductive Systems, Including Sexually Transmitted Infections”
This chapter covers alterations of the female and male reproductive systems. It also explores the epidemiology, clinical manifestations, evaluation, and treatment of sexually transmitted infections.
Poole Arcangelo, V., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins.
o Chapter 4, “Principles of Pharmacotherapy in Pediatrics” (Review)
This chapter explores concepts relating to drug selection, administration, and interaction for pediatric patients. It also compares age-related pharmacokinetic differences in children and adults.
o Chapter 6, “Principles of Pharmacotherapy in Elderly Patients” (Review)
This chapter describes issues and factors that affect drug therapy for elderly patients. It then explores concepts relating to drug selection, administration, and management for elderly patients.
o Chapter 33, “Prostatic Disorders and Erectile Dysfunction”
This chapter examines the causes, pathophysiology, and drug treatment of four disorders: prostatitis, benign prostatic hyperplasia, prostate cancer, and erectile dysfunction. It also explores the importance of monitoring patient response and patient education.
o Chapter 34, “Overactive Bladder”
This chapter describes the causes, pathophysiology, diagnostic criteria, and evaluation of overactive bladder. It also outlines the process of initiating, administering, and managing drug treatment for this disorder.
o Chapter 55, “Contraception”
This chapter examines various methods of contraception. It also covers drug interactions, selecting the most appropriate agent, and monitoring patient response to contraception.
o Chapter 56, “Menopause and Menopausal Hormone Therapy”
This chapter presents various options for menopausal hormone therapy. It also examines the strengths and limitations of each form of therapy.
o Chapter 57, “Osteoporosis”
This chapter covers various options for treating osteoporosis. It also describes proper dosages, potential adverse reactions, and special considerations of each drug.
o Chapter 58, “Vaginitis”
This chapter examines various causes of vaginitis. It also explores the diagnostic criteria and methods of treatment for the disorder.
Hilmer, S. N., McLachlan, A. J., & Le Couteur, D. G. (2007). Clinical pharmacology in the geriatric patient. Fundamental & Clinical Pharmacology, 21(3), 217–230.
Retrieved from the Walden Library databases.
This article explores issues that health care providers consider when prescribing drug treatment to geriatric patients. It also examines the role of polypharmacy in adverse drug reactions and the importance of managing patient response to drug treatment.
Drugs.com. (2012). Retrieved from www.drugs.com
This website presents a comprehensive review of prescription and over-the-counter drugs, including information on common uses and potential side effects. It also provides updates relating to new drugs on the market, support from health professionals, and a drug-drug interactions checker.
U.S. Preventive Services Task Force. (2012). Recommendations for adults [Online guidelines]. Retrieved from http://www.uspreventiveservicestaskforce.org/adultrec.htm
This website lists various preventive services available for men and women. It provides information about available screenings, tests, preventive medication, and counseling. Media
· Laureate Education, Inc. (Executive Producer). (2012d). Final course review . Baltimore, MD: Author.
This media is an interactive final review covering course content from Weeks 7–11. Optional Resources
· Centers for Disease Control and Prevention. (n.d.). Retrieved August 10, 2012, from http://www.cdc.gov
· Haymarket Media, Inc. (2012). Monthly prescribing reference [Online database]. Retrieved from http://www.empr.com/
· Institute for Safe Medication Practices. (2012). Retrieved from http://www.ismp.org/
· Medscape. (2012). Retrieved from http://www.medscape.com/